The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Angiotensin II for the Treatment of Vasodilatory Shock
Open accessAbstract
BACKGROUND: Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this condition. METHODS: We randomly assigned patients with vasodilatory shock who were receiving more than 0.2 μg of norepinephrine per kilogram of body weight per minute or the equivalent dose of another vasopressor to receive infusions of either angiotensin II or placebo. The primary end point was a response with respect to mean arterial pressure at hour 3 after the start of infusion, with response defined as an increase from baseline of at least 10 mm Hg or an increase to at least 75 mm Hg, without an increase in the dose of background vasopressors. RESULTS: A total of 344 patients were assigned to one of the two regimens; 321 received a study intervention (163 received angiotensin II, and 158 received placebo) and were included in the analysis. The primary end point was reached by more patients in the angiotensin II group (114 of 163 patients, 69.9%) than in the placebo group (37 of 158 patients, 23.4%) (odds ratio, 7.95; 95% confidence interval [CI], 4.76 to 13.3; P<0.001). At 48 hours, the mean improvement in the cardiovascular Sequential Organ Failure Assessment (SOFA) score (scores range from 0 to 4, with higher scores indicating more severe dysfunction) was greater in the angiotensin II group than in the placebo group (-1.75 vs. -1.28, P=0.01). Serious adverse events were reported in 60.7% of the patients in the angiotensin II group and in 67.1% in the placebo group. Death by day 28 occurred in 75 of 163 patients (46%) in the angiotensin II group and in 85 of 158 patients (54%) in the placebo group (hazard ratio, 0.78; 95% CI, 0.57 to 1.07; P=0.12). CONCLUSIONS: Angiotensin II effectively increased blood pressure in patients with vasodilatory shock that did not respond to high doses of conventional vasopressors. (Funded by La Jolla Pharmaceutical Company; ATHOS-3 ClinicalTrials.gov number, NCT02338843 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“There are data from RCTs in specific conditions such as pneumonia (286-289), urinary tract infections (290), bacteremia (291, 292), and intraabdominal infections (293).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [291]
Experimental — accuracy not yet measuredIn the citing paper
“The primary endpoint, an increase of MAP of at least 10 mmHg or to at least 75 mmHg, was achieved in 114 of 163 patients in the angiotensin II group and in 37 of 158 patients in the placebo group (69.9% vs 23.4%, p < 0.001).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [366]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Mayr, F., Yende, S. P., & Angus, D. C. (2013) · Virulence · doi:10.4161/viru.27372 · Cited by 1,298
López, A., Lorente, J. A., Steingrub, J. S., Bakker, J., McLuckie, A., Willatts, S. M., Brockway, M., Anzueto, A., Holzapfel, L., Breen, D. P., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000105581.01815.c6 · Cited by 917
Morelli, A., Ertmer, C., Westphal, M., Rehberg, S. W., Kampmeier, T., Ligges, S., Orecchioni, A., D’Egidio, A., D''Ippoliti, F., Raffone, C., et al. (2013) · JAMA · doi:10.1001/jama.2013.278477 · Cited by 739
History about the discovery of the renin-angiotensin system.
Basso, N., & Terragno, N. (2001) · HYPERTENSION · doi:10.1161/hy1201.101214 · Cited by 236
Survival After Shock Requiring High-Dose Vasopressor Therapy
Brown, S. M., Lanspa, M. J., Jones, J. P., Kuttler, K. G., Li, Y., Carlson, R., Miller, R. R., Hirshberg, E. L., Grissom, C. K., & Morris, A. H. (2013) · CHEST Journal · doi:10.1378/chest.12-1106 · Cited by 211
Flagged first, then by citations
Research works printed but not linked: 2
- Chawla LS, 2017, Crit Care Resusc, 19, 43
- Bassi E, 2013, Crit Care Res Pract, 2013, 654708
Cited by
Sorted by citations
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citationTrends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask‐Andersen, M., Schiöth, H. B., & Gloriam, D. E. I. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,714
Cecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30696-2 · Cited by 2,254
Peerapornratana, S., Manrique‐Caballero, C. L., Gómez, H., & Kellum, J. A. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.026 · Cited by 1,557
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
Lambden, S., Laterre, P., Levy, M. M., & François, B. (2019) · Critical Care · doi:10.1186/s13054-019-2663-7 · Cited by 1,043
Sepsis associated acute kidney injury
Poston, J. T., & Koyner, J. L. (2019) · BMJ · doi:10.1136/bmj.k4891 · Cited by 917
Mechanisms and treatment of organ failure in sepsis
Lelubre, C., & Vincent, J. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0005-7 · Cited by 877
Zarbock, A., Nadim, M. K., Pickkers, P., Gómez, H., Bell, S., Joannidis, M., KASHANI, K. B., Koyner, J. L., Pannu, N., Meersch, M., et al. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00683-3 · Cited by 875
Self-citationCOVID-19, ACE2, and the cardiovascular consequences
South, A. M., Diz, D. I., & Chappell, M. C. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00217.2020 · Cited by 797
Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment
Wang, Y., & Bellomo, R. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.119 · Cited by 794
Self-citationAcute kidney injury in the critically ill: an updated review on pathophysiology and management
Pickkers, P., Darmon, M., Hoste, E. A. J., Joannidis, M., Legrand, M. M., Ostermann, M., Prowle, J. R., Schneider, A. G., & Schetz, M. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06454-7 · Cited by 602
Self-citationFujii, T., Luethi, N., Young, P. J., Frei, D. R., Eastwood, G. M., French, C. J., Deane, A. M., Shehabi, Y., Hajjar, L. A., Oliveira, G., et al. (2020) · JAMA · doi:10.1001/jama.2019.22176 · Cited by 466
Self-citationSepsis and Septic Shock – Basics of diagnosis, pathophysiology and clinical decision making
Font, M. D., Thyagarajan, B., & Khanna, A. K. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.02.011 · Cited by 452
Self-citationLamontagne, F., Richards-Belle, A., Thomas, K., Harrison, D. A., Sadique, M. Z., Grieve, R. D., Camsooksai, J., Darnell, R., Gordon, A. C., Henry, D., et al. (2020) · JAMA · doi:10.1001/jama.2020.0930 · Cited by 354
Vasoactive-Inotropic Score: Evolution, Clinical Utility, and Pitfalls
Belletti, A., Lerose, C. C., Zangrillo, A., & Landoni, G. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.09.117 · Cited by 299
Tumlin, J. A., Murugan, R., Deane, A. M., Ostermann, M., Busse, L. W., Ham, K. R., KASHANI, K. B., Szerlip, H. M., Prowle, J. R., Bihorac, A., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003092 · Cited by 294
Self-citationSurviving sepsis campaign: research priorities for sepsis and septic shock
Coopersmith, C. M., Backer, D. D., Deutschman, C. S., Ferrer, R., Lat, I., Machado, F. R., Martin, G. S., Martín‐Loeches, I., Nunnally, M., Antonelli, M. M., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5175-z · Cited by 292
White, K. C., Neto, A. S., Hurford, R., Clément, P., Laupland, K. B., See, E. J., McCullough, J., White, H. T., Shekar, K., Tabah, A., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07138-0 · Cited by 261
Self-citationThe Sequential Organ Failure Assessment (SOFA) Score: has the time come for an update?
Moreno, R. P., Rhodes, A., Piquilloud, L., Glenn Hernández, P., Takala, J. A., Gershengorn, H. B., Tavares, M., Coopersmith, C. M., Myatra, S. N., Singer, M., et al. (2023) · Critical Care · doi:10.1186/s13054-022-04290-9 · Cited by 258
Definitions and pathophysiology of vasoplegic shock
Lambden, S., Creagh-Brown, B. C., Hunt, J. E. A., Summers, C., & Forni, L. G. (2018) · Critical Care · doi:10.1186/s13054-018-2102-1 · Cited by 265
Vasoplegia treatments: the past, the present, and the future
Lévy, B., Fritz, C., Tahon, E., Jacquot, A., Auchet, T., & Kimmoun, A. (2018) · Critical Care · doi:10.1186/s13054-018-1967-3 · Cited by 252
Bellomo, R., Forni, L. G., Busse, L. W., McCurdy, M. T., Ham, K. R., Boldt, D. W., Hästbacka, J., Khanna, A. K., Albertson, T. E., Tumlin, J. A., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201911-2172oc · Cited by 242
Self-citationManagement of Refractory Vasodilatory Shock
Jentzer, J. C., Vallabhajosyula, S., Khanna, A. K., Chawla, L. S., Busse, L. W., & KASHANI, K. B. (2018) · CHEST Journal · doi:10.1016/j.chest.2017.12.021 · Cited by 241
Self-citationVasopressor therapy in critically ill patients with shock
Russell, J. A. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05801-z · Cited by 247
Busse, L. W., Barker, N. A., & Petersen, C. (2020) · Critical Care · doi:10.1186/s13054-020-2743-8 · Cited by 242
Self-citationSepsis and septic shock: Guideline-based management
Dugar, S. P., Choudhary, C., & Duggal, A. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.18143 · Cited by 248
Current use of vasopressors in septic shock
Scheeren, T., Bakker, J., Backer, D. D., Annane, D., Asfar, P., Boerma, E. C., Cecconi, M., Dubín, A., Dünser, M. W., Duranteau, J., et al. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0498-7 · Cited by 204
Sepsis and septic shock: current approaches to management
Thompson, K., Venkatesh, B., & Finfer, S. R. (2019) · Internal Medicine Journal · doi:10.1111/imj.14199 · Cited by 207
Self-citationButler, D., Mozsary, C., Meydan, C., Foox, J., Rosiene, J. A., Shaiber, A., Danko, D., Afshinnekoo, E., MacKay, M. J., Sedlazeck, F. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21361-7 · Cited by 200
Sepsis: key insights, future directions, and immediate goals. A review and expert opinion
Martín‐Loeches, I., Singer, M., & Léone, M. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07694-z · Cited by 190
Vasoplegia After Cardiovascular Procedures—Pathophysiology and Targeted Therapy
Shaefi, S., Mittel, A. M., Klick, J. C., Evans, A. S., Ivascu, N. S., Gutsche, J. T., & Augoustides, J. G. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.10.032 · Cited by 189
A plea for personalization of the hemodynamic management of septic shock
Backer, D. D., Cecconi, M., Chew, M. S., Hajjar, L. A., Monnet, X., Ospina-Tascón, G. A., Ostermann, M., Pinsky, M. R., & Vincent, J. (2022) · Critical Care · doi:10.1186/s13054-022-04255-y · Cited by 187
Self-citationSepsis‐induced acute kidney injury: A disease of the microcirculation
Ma, S., Evans, R. G., Iguchi, N., Tare, M., Parkington, H. C., Bellomo, R., May, C. N., & Lankadeva, Y. R. (2018) · Microcirculation · doi:10.1111/micc.12483 · Cited by 189
Self-citationAn updated “norepinephrine equivalent” score in intensive care as a marker of shock severity
Kotani, Y., Gioia, A. D., Landoni, G., Belletti, A., & Khanna, A. K. (2023) · Critical Care · doi:10.1186/s13054-023-04322-y · Cited by 186
Self-citationVasopressor dose equivalence: A scoping review and suggested formula
Goradia, S., Sardaneh, A. A., Narayan, S. W., Penm, J. H.-D., & Patanwala, A. E. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.11.002 · Cited by 175
Vincent, J., Nielsen, N. D., Shapiro, N. I., Gerbasi, M. E., Grossman, A., Doroff, R., Zeng, F., Young, P. J., & Russell, J. A. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0448-9 · Cited by 174
Self-citationCurrent practice and evolving concepts in septic shock resuscitation
Bakker, J., Kattan, E., Annane, D., Castro, R., Cecconi, M., Backer, D. D., Dubín, A., Evans, L., Gong, M. N., Hamzaoui, O., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06595-9 · Cited by 158
Self-citationSantacruz, C. A., Pereira, A. J., Celis, É., & Vincent, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004000 · Cited by 155
Laterre, P.-F., Berry, S. M., Blemings, A., Carlsen, J. E., François, B., Graves, T., Jacobsen, K., Lewis, R. J., Opal, S. M., Perner, A., et al. (2019) · JAMA · doi:10.1001/jama.2019.14607 · Cited by 147
Self-citationPathophysiology of Septic Shock
Russell, J. A., Rush, B. N. M., & Boyd, J. H. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.08.005 · Cited by 147
A global perspective on vasoactive agents in shock
Annane, D., Ouanes-Besbes, L., Backer, D. D., Du, B., Gordon, A. C., Glenn Hernández, P., Olsen, K. M., Osborn, T. M., Peake, S., Russell, J. A., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5242-5 · Cited by 147
Atrial Arrhythmias in COVID-19 Patients
Colon, C. M., Barrios, J. G., Chiles, J. W., McElwee, S., Russell, D. W., Maddox, W. R., & Kay, G. N. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.05.015 · Cited by 138
Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026
Prescott, H. C., Antonelli, M. M., Alhazzani, W. A., Møller, M. H., Alshamsi, F. E., Azevedo, L. C. P., Belley‐Côté, E. P., Waele, J. D., Derde, L. P. G., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 140
Self-citationBellomo, R., Wunderink, R. G., Szerlip, H. M., English, S. W., Busse, L. W., Deane, A. M., Khanna, A. K., McCurdy, M. T., Ostermann, M., Young, P. J., et al. (2020) · Critical Care · doi:10.1186/s13054-020-2733-x · Cited by 131
Self-citationNet ultrafiltration intensity and mortality in critically ill patients with fluid overload
Murugan, R., Balakumar, V., Kerti, S. J., Priyanka, P., Chang, C. H., Clermont, G., Bellomo, R., Palevsky, P. M., & Kellum, J. A. (2018) · Critical Care · doi:10.1186/s13054-018-2163-1 · Cited by 124
Self-citationVasopressors in septic shock: which, when, and how much?
Shi, R., Hamzaoui, O., Vita, N. D., Monnet, X., & Teboul, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.04.24 · Cited by 126
Yealy, D. M., Mohr, N. M., Shapiro, N. I., Venkatesh, A. K., Jones, A. E., & Self, W. H. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.02.006 · Cited by 123
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Self-citationSurviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock
Coopersmith, C. M., Backer, D. D., Deutschman, C. S., Ferrer, R., Lat, I., Machado, F. R., Martin, G. S., Martín‐Loeches, I., Nunnally, M., Antonelli, M. M., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003225 · Cited by 117
Lankadeva, Y. R., Kosaka, J., Evans, R. G., Bellomo, R., & May, C. N. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002797 · Cited by 113
Self-citationCOVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
Rysz, S., Al-Saadi, J., Sjöström, A., Farm, M., Campoccia Jalde, F., Plattén, M., Eriksson, H., Klein, M., Vargas-Paris, R., Nyrén, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22713-z · Cited by 111
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
Papp, Z., Agostoni, P., Álvarez, J., Béttex, D., Bouchez, S., Brito, D. A., Černý, V., Colet, J. C., Crespo-Leiro, M. G., Delgado, J. F., et al. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000859 · Cited by 110
Pathological Role of Angiotensin II in Severe COVID-19
Miesbach, W. (2020) · TH Open · doi:10.1055/s-0040-1713678 · Cited by 110
Legrand, M. M., Bagshaw, S. M., Bhatraju, P. K., Bihorac, A., Caniglia, E. C., Khanna, A. K., Kellum, J. A., Koyner, J. L., Harhay, M. O., Zampieri, F. G., et al. (2024) · Critical Care · doi:10.1186/s13054-024-04877-4 · Cited by 111
Self-citationPeng, K., McIlroy, D. R., Bollen, B. A., Billings, F. T., Zarbock, A., Popescu, W. M., Fox, A. A., Shore-Lesserson, L. J., Zhou, S., Geube, M., et al. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006068 · Cited by 103
Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial
Ibarra-Estrada, M. Á., Kattan, E., Aguilera-González, P. E., Sandoval-Plascencia, L., Rico-Jauregui, U., Gomez-Partida, C. A., Ortiz-Macías, I. X., Pulgarín, J. A. L., Chávez-Peña, Q., Mijangos, J., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04397-7 · Cited by 103
Cioccari, L., Luethi, N., Bailey, M., Shehabi, Y., Howe, B. D., Messmer, A. S., Proimos, H., Peck, L., Young, H., Eastwood, G. M., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03115-x · Cited by 102
Self-citationClassic and Nonclassic Renin-Angiotensin Systems in the Critically Ill
Bitker, L., & Burrell, L. M. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.002 · Cited by 102
Vasopressor Therapy in the Intensive Care Unit
Russell, J. A., Gordon, A. C., Williams, M. D., Boyd, J. H., Walley, K. R., & Kissoon, N. “. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1710320 · Cited by 99
Renin–Angiotensin–Aldosterone System and Immunomodulation: A State-of-the-Art Review
Laghlam, D., Jozwiak, M., & Nguyen, L. S. (2021) · Cells · doi:10.3390/cells10071767 · Cited by 96
Fine‐Tuning the Proteolytic Stability of Peptides with Fluorinated Amino Acids
Huhmann, S., & Koksch, B. (2018) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201800803 · Cited by 95
Wieruszewski, P. M., Léone, M., Kaas‐Hansen, B. S., Dugar, S. P., Legrand, M. M., McKenzie, C., Bissell, B. D., Messina, A., Nasa, P., Schorr, C., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006176 · Cited by 95
Self-citationChallenges in the management of septic shock: a narrative review
Backer, D. D., Cecconi, M., Lipman, J., Machado, F. R., Myatra, S. N., Ostermann, M., Perner, A., Teboul, J., Vincent, J., & Walley, K. R. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05544-x · Cited by 95
Self-citationKlijian, A., Khanna, A. K., Reddy, V. S., Friedman, B. C., Ortoleva, J. P., Evans, A. S., Panwar, R., Kroll, S., Greenfeld, C. R., & Chatterjee, S. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.08.001 · Cited by 90
Self-citationSepsis-Associated Acute Kidney Injury
Alobaidi, R., & Bagshaw, S. M. (2019) · Springer eBooks · doi:10.1007/978-981-13-2276-1_20 · Cited by 88
for the Randomized controlled Evaluation of high-volume hemofiltration in adult burn patients with Septic shoCk and acUte kidnEy injury (RESCUE) Investigators, Chung, K. K., Coates, E. C., Smith, D. J., Karlnoski, R., Hickerson, W. L., Arnold-Ross, A., Mosier, M. M., Halerz, M. M., Sprague, A., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1878-8 · Cited by 87
Datt, V., Wadhhwa, R., Sharma, V., Virmani, S., Minhas, H. S., & Malik, S. (2021) · Journal of Cardiac Surgery · doi:10.1111/jocs.15805 · Cited by 87
What's New in Cardiopulmonary Bypass
Hessel, E. A. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.01.039 · Cited by 86
Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock*
Roberts, R. J., Miano, T. A., Hammond, D. A., Patel, G. P., Chen, J., Phillips, K. M., Lopez, N. D., KASHANI, K. B., Qadir, N., Cairns, C. B., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004476 · Cited by 86
Self-citationSepsis-induced AKI: From pathogenesis to therapeutic approaches
He, F.-F., Wang, Y., Chen, Y., Huang, W. C., Li, Z., & Zhang, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.981578 · Cited by 86
Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes
Weiss, S. L., & Fitzgerald, J. C. (2023) · PEDIATRICS · doi:10.1542/peds.2023-062967 · Cited by 88
Vasopressor Therapy in Cardiac Surgery—An Experts’ Consensus Statement
Guarracino, F., Habicher, M., Treskatsch, S., Sander, M., Székely, A. D., Paternoster, G., Salvi, L., Łysenko, L., Gaudard, P., Giannakopoulos, P., et al. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.11.032 · Cited by 84
Predictors of response to fixed-dose vasopressin in adult patients with septic shock
Sacha, G. L., Lam, S. W., Duggal, A., Torbic, H., Bass, S. N., Welch, S. C., Butler, R. S., & Bauer, S. R. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0379-5 · Cited by 84
Role of perioperative hypotension in postoperative acute kidney injury: a narrative review
Lankadeva, Y. R., May, C. N., Bellomo, R., & Evans, R. G. (2022) · British Journal of Anaesthesia · doi:10.1016/j.bja.2022.03.002 · Cited by 79
Self-citationVasopressor and Inotrope Therapy in Cardiac Critical Care
Jentzer, J. C., & Hollenberg, S. M. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620917630 · Cited by 77
Treatment of Acute Kidney Injury: A Review of Current Approaches and Emerging Innovations
Tamargo, C. L., Hanouneh, M. A., & Cervantes, C. E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092455 · Cited by 81
Angiotensin II Infusion for Shock
Wieruszewski, P. M., Wittwer, E. D., KASHANI, K. B., Brown, D. R., Butler, S. O., Clark, A., Cooper, C. J., Davison, D. L., Gajic, O., Gunnerson, K. J., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.08.2074 · Cited by 75
Wieruszewski, P. M., Bellomo, R., Busse, L. W., Ham, K. R., Zarbock, A., Khanna, A. K., Deane, A. M., Ostermann, M., Wunderink, R. G., Boldt, D. W., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04446-1 · Cited by 75
Self-citationTiming of vasoactive agents and corticosteroid initiation in septic shock
Ammar, M. A., Ammar, A. A., Wieruszewski, P. M., Bissell, B. D., Long, M. T., Albert, L., Khanna, A. K., & Sacha, G. L. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01021-9 · Cited by 72
Self-citationThe initial resuscitation of septic shock
Cinel, I., Kasapoglu, U. S., Gul, F., & Dellinger, R. P. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.02.004 · Cited by 69
Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury
Leisman, D. E., Fernandes, T., Bijol, V., Abraham, M. N., Lehman, J. R., Taylor, M. D., Capone, C., Yaipan, O. Y., Bellomo, R., & Deutschman, C. S. (2020) · Kidney International · doi:10.1016/j.kint.2020.07.047 · Cited by 69
Self-citationMethylene blue administration in patients with refractory distributive shock – a retrospective study
Pořízka, M., Kopecký, P., Dvorakova, H., Kunstýř, J., Lipš, M., Michálek, P., & Balík, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58828-4 · Cited by 69
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
Papp, Z., Agostoni, P., Álvarez, J., Béttex, D., Bouchez, S., Brito, D. A., Černý, V., Colet, J. C., Crespo-Leiro, M. G., Delgado, J. F., et al. (2020) · Cardiac failure review · doi:10.15420/cfr.2020.03 · Cited by 68
Ltaief, Z., Ben‐Hamouda, N., Rancati, V., Gunga, Z., Marcucci, C., Kirsch, M. E. W., & Liaudet, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216407 · Cited by 74
Hypotension within one-hour from starting CRRT is associated with in-hospital mortality
Shawwa, K., Kompotiatis, P., Jentzer, J. C., Wiley, B. M., Williams, A. W., Dillon, J. J., Albright, R. C., & KASHANI, K. B. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.07.004 · Cited by 66
Hyperdynamic Left Ventricular Ejection Fraction in ICU Patients With Sepsis
Chotalia, M., Ali, M., Hebballi, R., Singh, H. K., Parekh, D., Bangash, M. N., & Patel, J. M. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005315 · Cited by 65
Renal Medullary Hypoxia: A New Therapeutic Target for Septic Acute Kidney Injury?
Lankadeva, Y. R., Okazaki, N., Evans, R. G., Bellomo, R., & May, C. N. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.10.004 · Cited by 65
Self-citationNovel Therapies for Acute Kidney Injury
Chen, H., & Busse, L. W. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.06.020 · Cited by 65
Self-citationJeyaraju, M., McCurdy, M. T., Levine, A. R., Devarajan, P., Mazzeffi, M. A., Mullins, K. E., Reif, M., Yim, D. N., Parrino, C. R., Lankford, A. S., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005143 · Cited by 62
Self-citationDevelopment and performance of a novel vasopressor-driven mortality prediction model in septic shock
Vallabhajosyula, S., Jentzer, J. C., Kotecha, A. A., Murphree, D. H., Barreto, E. F., Khanna, A. K., & Iyer, V. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0459-6 · Cited by 62
Self-citationManagement of Sepsis in Patients With Cirrhosis: Current Evidence and Practical Approach
Simonetto, D. A., Serafim, L. P., de Moraes, A. G., Gajic, O., & Kamath, P. S. (2018) · Hepatology · doi:10.1002/hep.30412 · Cited by 64
Chotalia, M., Ali, M., Alderman, J. E., Kalla, M., Parekh, D., Bangash, M. N., & Patel, J. M. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005167 · Cited by 61
Hall, A., Busse, L. W., & Ostermann, M. (2018) · Critical Care · doi:10.1186/s13054-018-1995-z · Cited by 60
Self-citationfor the SODA-BIC investigators, Fujii, T., Udy, A. A., Nichol, A., Bellomo, R., Deane, A. M., El-Khawas, K., Naorungroj, T., Neto, A. S., Bergin, H., et al. (2021) · Critical Care · doi:10.1186/s13054-020-03431-2 · Cited by 58
Self-citationMedical Therapy of Cardiogenic Shock: Contemporary Use of Inotropes and Vasopressors
Riccardi, M., Pagnesi, M., Chioncel, O. D., Mebazaa, A., Cotter, G., Gustafsson, F., Tomasoni, D., Latronico, N., Adamo, M., & Metra, M. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3162 · Cited by 58
Hajjar, L. A., Zambolim, C. M., Belletti, A., de Almeida, J. P., Gordon, A. C., Oliveira, G., Park, C. H. L., Fukushima, J. T., Rizk, S. I., Szeles, T. F., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004023 · Cited by 63
Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial Dysfunction
Rong, J., Tao, X., Lin, Y., Zheng, H., Ning, L., Lu, H. S., Daugherty, A., Shi, P. D., Mullick, A. E., Chen, S., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.318075 · Cited by 57
Panwar, R., Tarvade, S., Lanyon, N., Saxena, M. K., Bush, D., Hardie, M. J., Attia, J., Bellomo, R., & van Haren, F. M. P. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201912-2316oc · Cited by 56
Self-citationHam, K. R., Boldt, D. W., McCurdy, M. T., Busse, L. W., Favory, R., Gong, M. N., Khanna, A. K., Chock, S., Zeng, F., Chawla, L. S., et al. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0536-5 · Cited by 55
Self-citation
Metadata
- Authors
- Khanna, A., English, S. W., Wang, X. S., Ham, K., Tumlin, J., Szerlip, H., Busse, L. W., Altaweel, L., Albertson, T. E., Mackey, C., McCurdy, M. T., Boldt, D. W., Chock, S., Young, P. J., Krell, K., Wunderink, R. G., Ostermann, M., Murugan, R., Gong, M. N., Panwar, R., Hästbacka, J., Favory, R., Venkatesh, B., Thompson, B. T., Bellomo, R., Jensen, J., Kroll, S., Chawla, L. S., Tidmarsh, G. F., & Deane, A. M.
- Affiliations
- Cleveland Clinic (US)
- Regions Hospital (US)
- Inova Health System (US)
- Albert Einstein College of Medicine (US)
- University of Maryland, Baltimore (US)
- Northwestern University (US)
- ORCID
- Khanna, Ashish
- English, Shane W.
- Ham, Kealy
- Szerlip, Harold
- Busse, Laurence W.
- Albertson, Timothy E.
- McCurdy, Michael T.
- Young, Paul J.
- Wunderink, Richard G.
- Ostermann, Marlies
- Murugan, Raghavan
- Gong, Michelle N.
- Panwar, Rakshit
- Hästbacka, Johanna
- Venkatesh, Balasubramanian
- Thompson, B. Taylor
- Bellomo, Rinaldo
- Chawla, Lakhmir S.
- Deane, Adam M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-08-03
- Volume
- 377
- Issue
- 5
- Pages
- 419-430
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2614578436
- Cited by
- 916
- References
- 24
- Citations by year
- 2026: 100 · 2025: 103 · 2024: 121 · 2023: 103 · 2022: 90 · 2021: 95 · 2020: 123 · 2019: 80 · 2018: 75 · 2017: 25
- FWCI
- 64.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Figshare (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- GlaxoSmithKline
- La Jolla Pharmaceutical Company
- Alexion Pharmaceuticals
- Regeneron Pharmaceuticals
- Genentech
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Keywords
- angiotensin II, vasodilatory shock, septic shock, vasopressors, norepinephrine, mean arterial pressure, SOFA score, mortality, blood pressure response, adverse events, sepsis treatment, vasopressor-refractory shock, fluid resuscitation, vasopressor dose reduction, organ dysfunction, 28-day mortality
- MeSH terms
- Aged, Angiotensin II, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hypotension, Male, Middle Aged, Shock, Vasoconstrictor Agents, Organ Dysfunction Scores
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
